Genetic testing and familial implications in breast-ovarian cancer familiesOOSTERWIJK, Jan C; DE VRIES, Jakob; MOURITS, Marian J et al.Maturitas (Amsterdam). 2014, Vol 78, Num 4, pp 252-257, issn 0378-5122, 6 p.Article

One risk fits all? Authors' replyDE BOCK, Geertruida H; MOURITS, Marian J. E; OOSTERWIJK, Jan C et al.Journal of clinical oncology. 2007, Vol 25, Num 22, pp 3383-3384, issn 0732-183X, 2 p.Article

The validation of a simulation model incorporating radiation risk for mammography breast cancer screening in women with a hereditary-increased breast cancer riskGREUTER, Marcel J. W; JANSEN-VAN DER WEIDE, Marijke C; JACOBI, Cathrien E et al.European journal of cancer (1990). 2010, Vol 46, Num 3, pp 495-504, issn 0959-8049, 10 p.Article

The Dutch founder mutation SDHD.D92Y shows a reduced penetrance for the development of paragangliomas in a large multigenerational familyHENSEN, Erik F; JANSEN, Jeroen C; SIEMERS, Maaike D et al.European journal of human genetics. 2010, Vol 18, Num 1, pp 62-66, issn 1018-4813, 5 p.Article

Hereditary breast cancer growth rates and its impact on screening policyTILANUS-LINTHORST, Madeleine M. A; KRIEGE, Mieke; DE KONING, Harry J et al.European journal of cancer (1990). 2005, Vol 41, Num 11, pp 1610-1617, issn 0959-8049, 8 p.Article

Inheritance of most X-linked traits is not dominant or recessive, just X-linkedDOBYNS, William B; FILAURO, Allison; TOMSON, Brett N et al.American journal of medical genetics. 2004, Vol 129A, Num 2, pp 136-143, issn 0148-7299, 8 p.Article

A Nonsynonymous Polymorphism in IRS1 Modifies Risk of Developing Breast and Ovarian Cancers in BRCA1 and Ovarian Cancer in BRCA2 Mutation CarriersDING, Yuan C; MCGUFFOG, Lesley; KRISTOFFERSSON, Ulf et al.Cancer epidemiology, biomarkers & prevention. 2012, Vol 21, Num 8, pp 1362-1370, issn 1055-9965, 9 p.Article

BRCA1- Associated Breast Cancers Present Differently From BRCA2-Associated and Familial Cases: Long-Term Follow-Up of the Dutch MRISC Screening StudyRIJNSBURGER, Adriana J; OBDEIJN, Inge-Marie; PETERSE, Hans et al.Journal of clinical oncology. 2010, Vol 28, Num 36, pp 5265-5273, issn 0732-183X, 9 p.Article

Time to stop ovarian cancer screening in BRCA1/2 mutation carriers?VAN DER VELDE, Nienke M; MOURITS, Marian J. E; ARTS, Henriëtte J. G et al.International journal of cancer (Print). 2009, Vol 124, Num 4, pp 919-923, issn 0020-7136, 5 p.Article

Rare variants in XRCC2 as breast cancer susceptibility allelesHILBERS, Florentine S; WIJNEN, Juul T; COUCH, Fergus J et al.Journal of medical genetics. 2012, Vol 49, Num 10, pp 618-620, issn 0022-2593, 3 p.Article

Novel types of mutation responsible for the dermatosparactic type of Ehlers-Danlos syndrome (type VIIC) and common polymorphisms in the ADAMTS2 geneCOLIGE, Alain; NUYTINCK, Lieve; WOLFF, Gerhard et al.Journal of investigative dermatology. 2004, Vol 123, Num 4, pp 656-663, issn 0022-202X, 8 p.Article

The HLA class III subregion is responsible for an increased breast cancer riskDE JONG, Mirjam M; NOLTE, Ilja M; BOEZEN, H. Marike et al.Human molecular genetics (Print). 2003, Vol 12, Num 18, pp 2311-2319, issn 0964-6906, 9 p.Article

Relevance and efficacy of breast cancer screening in BRCA1 and BRCA2 mutation carriers above 60 years: A national cohort studySAADATMAND, Sepideh; VOS, Janet R; MEIJERS-HEIJBOER, Hanne et al.International journal of cancer (Print). 2014, Vol 135, Num 12, pp 2940-2949, issn 0020-7136, 10 p.Article

Risk-reducing mastectomy in BRCA1/2 mutation carriers: Factors influencing uptake and timingVAN DRIEL, Catheleine M; ELTAHIR, Yassir; DE VRIES, Jakob et al.Maturitas (Amsterdam). 2014, Vol 77, Num 2, pp 180-184, issn 0378-5122, 5 p.Article

Cost-Effectiveness of Screening Women With Familial Risk for Breast Cancer With Magnetic Resonance ImagingSAADATMAND, Sepideh; TILANUS-LINTHORST, Madeleine M. A; DE KONING, Harry J et al.Journal of the National Cancer Institute. 2013, Vol 105, Num 17, pp 1314-1321, issn 0027-8874, 8 p.Article

Factors affecting sensitivity and specificity of screening mammography and MRI in women with an inherited risk for breast cancerKRIEGE, Mieke; BREKELMANS, Cecile T. M; TILANUS-LINTHORST, Madeleine M. A et al.Breast cancer research and treatment. 2006, Vol 100, Num 1, pp 109-119, issn 0167-6806, 11 p.Article

Efficacy of MRI and mammography for breast-cancer screening in women with a familial or genetic predispositionKRIEGE, Mieke; BREKELMANS, Cecile T. M; MULLER, Sara H et al.The New England journal of medicine. 2004, Vol 351, Num 5, pp 427-437, issn 0028-4793, 11 p.Article

Autosomal recessive HEM/greenberg skeletal dysplasia is caused by 3β-hydroxysterol Δ¹⁴-reductase deficiency due to mutations in the lamin B receptor geneWATERHAM, Hans R; KOSTER, Janet; MOOYER, Petra et al.American journal of human genetics. 2003, Vol 72, Num 4, pp 1013-1017, issn 0002-9297, 5 p.Article

Targeted Prostate Cancer Screening in BRCA1 and BRCA2 Mutation Carriers: Results from the Initial Screening Round of the IMPACT StudyBANCROFT, Elizabeth K; PAGE, Elizabeth C; MAEHL, Lovise et al.European urology. 2014, Vol 66, Num 3, pp 489-499, issn 0302-2838, 11 p.Article

Proven non-carriers in BRCA families have an earlier age of onset of breast cancerVOS, Janet R; DE BOCK, Geertruida H; TEIXEIRA, Natalia et al.European journal of cancer (1990). 2013, Vol 49, Num 9, pp 2101-2106, issn 0959-8049, 6 p.Article

Support of the 'fallopian tube hypothesis' in a prospective series of risk-reducing salpingo-oophorectomy specimensREITSMA, Welmoed; DE BOCK, Geertruida H; OOSTERWIJK, Jan C et al.European journal of cancer (1990). 2013, Vol 49, Num 1, pp 132-141, issn 0959-8049, 10 p.Article

Differences in Natural History between Breast Cancers in BRCA1 and BRCA2 Mutation Carriers and Effects of MRI Screening-MRISC, MARIBS, and Canadian Studies CombinedHEIJNSDIJK, Eveline A. M; WARNER, Ellen; WARREN, Ruth M. L et al.Cancer epidemiology, biomarkers & prevention. 2012, Vol 21, Num 9, pp 1458-1468, issn 1055-9965, 11 p.Article

Breast cancer screening in BRCA1 and BRCA2 mutation carriers after risk reducing salpingo-oophorectomyFAKKERT, Ingrid E; JANSEN, Liesbeth; MEIJER, Kees et al.Breast cancer research and treatment. 2011, Vol 129, Num 1, pp 157-164, issn 0167-6806, 8 p.Article

Penetrance of breast cancer, ovarian cancer and contralateral breast cancer in BRCA1 and BRCA2 families: high cancer incidence at older ageVAN DER KOLK, Dorina M; DE BOCK, Geertruida H; LEEGTE, Beike K et al.Breast cancer research and treatment. 2010, Vol 124, Num 3, pp 643-651, issn 0167-6806, 9 p.Article

No increased susceptibility to breast cancer from combined CHEK2 1100delC genotype and the HLA class III region risk factorsDE JONG, Mirjam M; NOLTE, Ilja M; SCHAAPVELD, Michael et al.European journal of cancer (1990). 2005, Vol 41, Num 12, pp 1819-1823, issn 0959-8049, 5 p.Article